Klaus Luyken
Papers
4
Total Citations
68
H-Index
4
About
Klaus Luyken is a leading figure in stereotactic radiosurgery, whose work has fundamentally advanced the precision and safety of non-invasive brain treatments. His research centers on the comparative accuracy of robotic versus frame-based systems, the optimization of treatment planning for brain metastases, and the physical parameters that govern dose distribution. Luyken’s landmark 2014 study, cited 33 times, critically compared intracranial radiosurgery using an adapted linear accelerator against robotic platforms, establishing a benchmark for clinical decision-making. He further demonstrated the mechanical accuracy of the ROSA robotic system against the gold-standard Leksell frame in a 2022 phantom study (16 citations), providing essential validation for robotic adoption. Notably, Luyken pioneered a quality index for CyberKnife planning to minimize radiotoxicity, proposing a model to predict the lowest achievable V12—a key predictor of radionecrosis—for given tumor sizes and prescription doses. His 2021 investigation into prescription isodose levels and collimator selection (8 citations) has given clinicians a rigorous framework for balancing dose homogeneity with plan quality. Through these contributions, Luyken has directly improved patient outcomes by reducing complications and standardizing high-precision radiosurgery protocols.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4